state California RNA DNA state California

The latest round in the CRISPR patent battle has an apparent victor, but the fight continues

Reading now: 271
www.sciencemag.org

The genome editor CRISPR, whose invention is at the heart of a fierce patent battle, typically uses a RNA molecule (red) to guide a DNA-cutting enzyme such as Cas9 (orange) to a DNA sequence (blue) targeted for cutting.

By Jon CohenThe long-running patent battle over CRISPR, the genome editor that may bring a Nobel prize and many millions of dollars to whomever is credited with its invention, has taken a new twist that vastly complicates the claims made by a team led by the University of California.The Patent Trial and Appeal Board (PTAB) ruled 10 September that a group led by the Broad Institute has “priority” in its already granted patents for uses of the original CRISPR system in eukaryotic cells, which covers potentially lucrative.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA